Corcept Therapeutics Incorporated (BIT:1CORT)
33.81
-1.24 (-3.54%)
At close: Feb 11, 2026
Corcept Therapeutics Market Cap
Corcept Therapeutics has a market cap or net worth of €3.62 billion as of February 11, 2026. Its market cap has decreased by -40.61% in one year.
Market Cap
3.62B
Enterprise Value
3.18B
Revenue
631.70M
Ranking
n/a
PE Ratio
40.58
Stock Price
€33.81
Market Cap Chart
Since April 14, 2004, Corcept Therapeutics's market cap has increased from 232.16M to 3.62B, an increase of 1,459.12%. That is a compound annual growth rate of 13.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 3.62B | 16.10% |
| Dec 31, 2025 | 3.12B | -38.86% |
| Dec 31, 2024 | 5.10B | 68.36% |
| Dec 29, 2023 | 3.03B | 48.06% |
| Dec 30, 2022 | 2.05B | 10.92% |
| Dec 31, 2021 | 1.84B | -25.77% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SOL S.p.A. | 4.28B |
| Danieli & C. Officine Meccaniche | 4.16B |
| Nexi S.p.A. | 4.15B |
| DiaSorin | 4.02B |
| Reply | 3.68B |
| Technogym | 3.58B |
| Iren SpA | 3.58B |
| Webuild | 3.55B |